Skip to content
MarketScale
‹ Back to IndustriesHealthcare

M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area, On My Care was acquired by Excelin Health, a portfolio company of Corinthian Equity Fund II, L.P.

“We are excited to add On My Care to our larger portfolio and continue their tradition of excellence. Andre Ulloa and his team at M&A Healthcare Advisors went above and beyond to shepherd this transaction through closing and were integral to getting the deal done. Andre was the consummate intermediary: attentive, responsive, and consistent throughout the entire process.” – Maureen Spivack, President of MAS Advisory Services, LLC and Board Member of Excelin Health.

While the current M&A market has shown signs of slowing down in recent months, with the right support and guidance, transactions are still occurring. The M&A Healthcare Advisors team was able to create increased value for On My Care, successfully navigate through every phase of the sale process, and identify a buyer with unique synergies who would continue building upon their legacy.

“We regularly speak about how our involvement directly increases the probability of a company being sold and drives the enterprise value of the businesses we represent. The sale process for On My Care Home Health is a direct testament to those principles, our experience, and Andre’s remarkable daily effort to ensure the best outcome for our client”, say Co-Founders Mike Moran & Mark Thomas

This success proves the effectiveness of M&A Healthcare Advisors’ approach only 8 months after their founding.

“The team at M&A Healthcare Advisors [MAHA] was the perfect complement for us as a seller. They matched my work ethic and quick responsiveness. They were supportive, taking on all sale’s process tasks which did not require my involvement, allowing me to focus on my operations.

Although the tangible work product was excellent, what was most impressive to me was their technical consistency and emotional fortitude through a very arduous due diligence process. There were many evenings we would spend on the phone assessing that day’s events and adjusting our approach for the days to come. MAHA introduced me to our transactional attorneys, as well; all the while working side-by-side with the legal team to ensure that every aspect of the purchase agreement was as good as it could be.

In the end, after an eight-month process, all parties walked away with a mutually beneficial deal. I thank that, in large part, to the efforts of MAHA.” – Hans Gill, CEO of On My Care Home Health

About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Our core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses. Our team is highly accessible, experienced, process-driven, and seeks to bring a superior level of guidance to every engagement. We relentlessly advocate for our clients, constantly reinforcing the most essential value: TRUST.

With over 50 successful healthcare transactions in the past five years, the team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Not-for-Profits and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact

Mark Thomas

Partner, Director of Operations

M&A Healthcare Advisors

mthomas@mahealthcareadvisors.com

Media Contact

Matt Santoro

matt@elkordyglobal.com

SOURCE M&A Healthcare Advisors

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Hospitals need a shortlist as cardiology AI clearances hit 225

Hospitals need a shortlist as cardiology AI clearances hit 225

Cardiology now has 225 FDA-cleared AI algorithms when imaging is included. That volume is the problem. Health systems now need tighter governance, integration checks, and clinical workflow evidence to decide what ships.

  • 01The useful benchmark for governance committees is scale: FDA-cleared AI totals 1,524 overall, with radiology at 1,163 and cardiology at 225 when CV imaging is included, according to Cardiovascular Business.
  • 02Procurement risk is shifting from “is it cleared?” to “where does it run?” because new clearances span cath lab guidance, echo quantification, remote monitoring, and image assessment tools that touch different systems of record.
  • 03AliveCor shows the long game: Healio reported 510(k) clearance for an ECG AI suite in 2020, and Cardiovascular Business listed a new clearance in 2026, a reminder to vet update cadence and post-clearance support.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512